Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
Narat Srivali, Assistant Professor at Duke University Medical Center, shared on LinkedIn about a recent article he and Federica De Giacomi co-authored, published in Expert Opinion on Pharmacotherapy, adding:
”Excited to share our new systematic review and meta-analysis on glucocorticoid therapy and the risk of venous thromboembolism (VTE).
We found that glucocorticoid use is associated with an approximately 2.6-fold increased risk of VTE, with the highest risk seen early in treatment, at higher doses, and with systemic formulations.
These findings may help clinicians think more carefully about VTE risk stratification when initiating glucocorticoids, especially in patients with additional risk factors.”
Title: Glucocorticoid therapy and risk of venous thromboembolism: a systematic review and meta-analysis with exploration of dose, duration, and route-specific effects
Authors: Narat Srivali, Federica De Giacomi
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026